Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00130793
Status:
COMPLETED
Last Update Posted:
2015-01-26
First Post:
2005-08-11
Brief Title:
A Study to Evaluate Safety Tolerability and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella ChickenpoxV211-010COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Double-Blind Randomized Controlled Multicenter Study to Evaluate the Safety Tolerability and Immunogenicity of a Refrigerator-Stable Formulation of Zoster Vaccine Live OkaMerck
Status:
COMPLETED
Status Verified Date:
2015-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether the refrigerator-stable formulation of an investigational vaccine has a comparable immune response the bodys ability to protect against disease and safety profile to that of the freezer-stable formulation of the vaccine
Detailed Description:
The duration of treatment is 4 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005_035 | None | None | None |